Citius Oncology (CTOR) Restructuring Costs (2023 - 2026)
Citius Oncology (CTOR) posted quarterly Restructuring Costs of $567937.0 for Q1 2026, little changed year-over-year from $567937.0 in Q1 2025, and up 14.06% quarter-over-quarter from $497937.0 in Q4 2025.
Citius Oncology (CTOR) Restructuring Costs (2023 - 2026) Analysis & Trends
Citius Oncology (CTOR) has reported Restructuring Costs for 4 consecutive years, with $567937.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Restructuring Costs changed 0.0% year-over-year to $567937.0; the TTM figure through Mar 2026 stood at $2.1 million (down 35.83% YoY), while the FY2025 annual figure was $2.2 million, up 19.26% from the prior year.
- Restructuring Costs rose to $567937.0 in Q1 2026 per CTOR's latest filing, from $497937.0 in the prior quarter.
- Across five years, Restructuring Costs topped out at $1.3 million in Q2 2024 and bottomed at $30000.0 in Q1 2023.
- Historically, Restructuring Costs has averaged $502161.5 across 4 years, with a median of $532937.0 in 2024.
- Annual changes were most pronounced in 2024 — Restructuring Costs surged 4334.55% — and 2025, when it tumbled 57.31%.
- Citius Oncology's Restructuring Costs stood at $422282.0 in 2023, then soared by 34.49% to $567937.0 in 2024, then declined by 12.33% to $497937.0 in 2025, then rose by 14.06% to $567937.0 in 2026.
- Business Quant data shows CTOR's Restructuring Costs at $567937.0 in Q1 2026, $497937.0 in Q4 2025, and $497931.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 44.07 Bn | 43.10 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.42 Bn | 39.76 Bn | 2.15 Bn |
| 3 | Zoetis | 31.86 Bn | 30.18 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.77 Bn | 22.98 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.29 Bn | 19.63 Bn | 683.80 Mn |
| 6 | Viatris | 18.78 Bn | 17.89 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.66 Bn | 15.27 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.91 Bn | 11.38 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 10.00 Bn | - |
| 10 | Citius Oncology | 76.95 Mn | 76.95 Mn | 1.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 567,937.00 |
| Dec 31, 2025 | 497,937.00 |
| Sep 30, 2025 | 497,931.00 |
| Jun 30, 2025 | 567,937.00 |
| Mar 31, 2025 | 567,937.00 |
| Dec 31, 2024 | 567,937.00 |
| Jun 30, 2024 | 1.33 Mn |
| Mar 31, 2024 | 855,676.00 |
| Dec 31, 2023 | 422,282.00 |
| Sep 30, 2023 | 90,000.00 |
| Jun 30, 2023 | 30,000.00 |
| Mar 31, 2023 | 30,000.00 |